---
figid: PMC5240207__12868_2016_333_Fig10_HTML
figlink: /pmc/articles/PMC5240207/figure/Fig10/
number: Fig.Â 10
caption: A model of cell fate decision by poly(ADP-ribosyl)ation in NSPCs. In normal
  conditions, both ATM and ATR are poly(ADP-ribosyl)ated and inactivated, leading
  to dephosphorylation of p53 at Ser18. The resulting inactivation of p53 promotes
  the self-renewal of NSPCs and neurosphere formation. Under PARP inhibition, ATM
  and/or ATR without poly(ADP-ribosyl)ation are activated, leading to the phosphorylation
  and activation of p53. The activated p53 signaling pathway delays cell cycle progression
  and induces apoptosis by different mechanisms
pmcid: PMC5240207
papertitle: Poly(ADP-ribose) polymerase inhibitors activate the p53 signaling pathway
  in neural stem/progenitor cells.
reftext: Akiko Okuda, et al. BMC Neurosci. 2017;18:14.
pmc_ranked_result_index: '5610'
pathway_score: 0.7207359
filename: 12868_2016_333_Fig10_HTML.jpg
figtitle: Cell fate decision by poly(ADP-ribosyl)ation in NSPCs
year: '2017'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC5240207__12868_2016_333_Fig10_HTML.html
  '@type': Dataset
  description: A model of cell fate decision by poly(ADP-ribosyl)ation in NSPCs. In
    normal conditions, both ATM and ATR are poly(ADP-ribosyl)ated and inactivated,
    leading to dephosphorylation of p53 at Ser18. The resulting inactivation of p53
    promotes the self-renewal of NSPCs and neurosphere formation. Under PARP inhibition,
    ATM and/or ATR without poly(ADP-ribosyl)ation are activated, leading to the phosphorylation
    and activation of p53. The activated p53 signaling pathway delays cell cycle progression
    and induces apoptosis by different mechanisms
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - PARP14
  - TP53
  - PARP15
  - TIPARP
  - ATR
  - RPS18
  - PARP16
  - PARP10
  - PARP6
  - PARP11
  - PARP1
  - PARP4
  - ATM
  - TNKS
  - PARP2
  - PARP8
  - PARP9
  - TNKS2
  - PARP12
  - PARP3
genes:
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP14
  entrez: '54625'
- word: P-p53
  symbol: p53
  source: hgnc_alias_symbol
  hgnc_symbol: TP53
  entrez: '7157'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP15
  entrez: '165631'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TIPARP
  entrez: '25976'
- word: RATM/ATR
  symbol: ATR
  source: hgnc_symbol
  hgnc_symbol: ATR
  entrez: '545'
- word: (S18)
  symbol: S18
  source: hgnc_alias_symbol
  hgnc_symbol: RPS18
  entrez: '6222'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP16
  entrez: '54956'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP10
  entrez: '84875'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP6
  entrez: '56965'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP11
  entrez: '57097'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP1
  entrez: '142'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP4
  entrez: '143'
- word: ATM/ATR
  symbol: ATM
  source: hgnc_symbol
  hgnc_symbol: ATM
  entrez: '472'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS
  entrez: '8658'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP2
  entrez: '10038'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP8
  entrez: '79668'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP9
  entrez: '83666'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: TNKS2
  entrez: '80351'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP12
  entrez: '64761'
- word: PARP
  symbol: PARP
  source: bioentities_symbol
  hgnc_symbol: PARP3
  entrez: '10039'
chemicals: []
diseases: []
---
